BiomX Inc. (NYSE AMERICAN: PHGE)
$0.33
-0.0090 ( -2.65% ) 15.9K
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
Market Data
Open
$0.33
Previous close
$0.34
Volume
15.9K
Market cap
$23.19M
Day range
$0.33 - $0.36
52 week range
$0.19 - $0.86
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 09, 2023 |
10-q | Quarterly Reports | 54 | Aug 09, 2023 |
def | Proxies and info statements | 4 | Jul 28, 2023 |
pre | Proxies and info statements | 2 | Jul 14, 2023 |